We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App




MALDI-TOF MS Employed for Early Diagnosis of Bloodstream Infections

By LabMedica International staff writers
Posted on 17 Dec 2020
Bloodstream infections (BSIs) are a major cause of mortality in hospitalized patients. More...
Rapid diagnosis is crucial because any delay in the antimicrobial treatment is associated with an increase in adverse patient outcomes.

The routine identification of microorganisms in clinical microbiology laboratories is carried out by applying different tests, such as phenotypic essays based on microscopic, macroscopic, and biochemical analyses that allow determining their metabolic requirements, either manually or by automated systems.

A team of Medical Microbiologists at the Pontificia Universidad Javeriana (Bogotá, Colombia) analyzed 470 positive blood cultures from 190 patients’ samples using Standard Aerobic/F and Anaerobic/F blood culture media. Isolates were identified using conventional identification methods and by the direct method using the matrix-assisted laser desorption ionization-time of flight (MALDI-TOF MS) system.

All blood cultures were incubated in the BacT/ALERT blood culture system (bioMérieux, Marcy-L’Etoile, France). All isolates were identified using both conventional methods MicroScan WalkAway 96 Plus (Beckman Coulter, Brea, CA, USA), and MALDI-TOF MS.

The protein mass spectra were analyzed using the Flex Control software and the MALDI Biotyper version 3.1 7311 reference spectra (main spectra) (Bruker Daltonics, Bremen, Germany).

The team reported that in 470 blood cultures, the direct method showed good identification results (420/470, 89%); specifically, accurate species and genus identification in 283/470 (60%), and only correct genus identification in 137/470 (29%). The direct protocol had better performance for Gram-negative compared to Gram-positive bacteria (97% versus 76%) and was unable to identify the positive blood cultures for both yeasts and some bacteria, mostly Gram-positive (50/470).

The direct method was unable to identify the positive blood cultures for yeasts and for some bacteria such as Staphylococcus aureus 15/52, coagulase negative staphylococci 11/33, Salmonella spp. 3/3, Streptococcus salivarus 2/2, Actinomyces naeslundii 1/1, and Cutibacterium acnes 1/1. However, all strains of Staphylococcus aureus or coagulase negative staphylococci were identified through the conventional method.

The authors concluded that accurate identification of the pathogen species that cause an infection is paramount. Their study provided a rapid and easy method for the direct identification of pathogens from positive blood cultures. The in-house protocol used gave good and reliable results for Gram-negative bacteria and may be helpful for the identification of some Gram-positive bacteria. This allowed better use of the robust MALDI-TOF technology with results available up to 24 hours earlier, which could positively impact the treatment of patients. The study was published on December 1, 2020 in the International Journal of Infectious Diseases.

Related Links:
Pontificia Universidad Javeriana
bioMérieux
Beckman Coulter
Bruker Daltonics



New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Collection and Transport System
PurSafe Plus®
New
Gold Member
Automated MALDI-TOF MS System
EXS 3000
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.